Ethical Concerns about Psilocybin Intellectual Property.

MLA

Gerber, Konstantin, et al. “Ethical Concerns about Psilocybin Intellectual Property.” ACS Pharmacology & Translational Science, vol. 4, no. 2, Jan. 2021, pp. 573–77. EBSCOhost, https://doi.org/10.1021/acsptsci.0c00171.

APA

Gerber, K., Flores, I. G., Ruiz, A. C., Ali, I., Ginsberg, N. L., & Schenberg, E. E. (2021). Ethical Concerns about Psilocybin Intellectual Property. ACS Pharmacology & Translational Science, 4(2), 573–577. https://doi.org/10.1021/acsptsci.0c00171

Chicago

Gerber, Konstantin, Inti García Flores, Angela Christina Ruiz, Ismail Ali, Natalie Lyla Ginsberg, and Eduardo E Schenberg. 2021. “Ethical Concerns about Psilocybin Intellectual Property.” ACS Pharmacology & Translational Science 4 (2): 573–77. doi:10.1021/acsptsci.0c00171.